Biomeditsina va amaliyot jurnali, 2022 №3

Maqola mavzusi

LABORATORY - BIOCHEMICAL ANALYSIS IN PATIENTS OF MIDDLE AND OLD AGE WITH NONALCOHOLIC FATTY LIVER DISEASE COMPARATIVE ASSESMENT OF THE CHANGE AFTER INFECTION WITH COVID-19 (196-200)

Mualliflar

ZOKIROV Voxid Zoyitovich

Muassasa

Buxoro tibbiyot instituti

Annotatsiya

Ушбу мақолада CОВИД-19 ўтказган ўрта ва кекса ёшли беморларда жигар ноалкогол ёғ хасталиги билан оғриган беморларда жигар функтсионал ҳолатини баҳолаш учун пигмент метаболизми, цитолиз ва холестаз параметрларининг махсус экспериментал таҳлил қилинди. Тадқиқот гуруҳидаги беморлар тадқиқот мобайнида жигарнинг алкагол ёғ хасталигини инкор этиш учун CАГЕ махсус сўровномасидан фойдаланиб ажратиб олинди ва экспрементал гуруҳ CОВИД-19 ташхиси қўйилган беморлардан анамнез (спиртли ичимликлардан вақти-вақти истемоли) йиғилди. CОВИД-19ни тасдиқлаш ПЗР тест асосида амалга оширилади

Kalit so'zlar

: CОВИД – 19, жигарни ноалкагол ёғ хасталиги, биокимёвий таҳлиллар, умумий билирубин, умумий холестерин, албумин.

Adabiyotlar

1. Yuldasheva D.H. Хamrayev A.A. Clinical, laboratory and molecular-genetic markers of the progression of non-alcoholic fatty liver disease (literature review and own data) // Society and innovations // Special Issue –2 (2021). – P. 399 – 406. 2. DH Yuldasheva, VZ Zokirov, Q Gulomova Sh. Non-alcoholic fatty liver disease: Modern view of the problem // A Multidisciplinary Peer Reviewed Journal. // Vol.6. Issue 12. Dec.2020. – P. 286 – 292 3. Yuldasheva D.H. Shadjanova N.S., Oltiboev R.O. Non-alcoholic fatty liver disease and modern medicine // Academicia an international multidisciplinary research journal // Vol.10. Issue 11. Nov.2020. – P. 1931 – 1937. 4. DH Yuldasheva, VZ Zokirov, RO Oltiboyev. Modern approaches to the pathogenesis of nonalcoholic fatty liver disease // Euro-Asia Conferences. // – 2021. – P. 384-389. 5. DH Yuldasheva, ZX Muxamedova, VZ Zokirov. Chronic liver disease and COVID-2019 // EConference Globe. // – 2021. – P. 193-197. 6. Nasirova Zarnigor Jasur qizi Zokirov Vohid Zohidovich, Yuldasheva Dilnavoz Xasanovna, Muxammedova Zarifa Ramazzonovna. Аssessment of comparative analysis of the course of non-alcoholic fatty liver disease in middle-aged and elderly patients who suffer covid-19 through ultrasound elastometry (via fibroscan). // World Bulletin of Public Health (WBPH) Available Online. // Vol.5. December-2021 – P. 64 – 66 7. Dilnavoz X. Yuldasheva Abror А. Хamrayev. Prevalence of non-alcoholic fatty liver disease, clinical and laboratory markers// Central Asian Journal of Medicine Volume // 2022 Issue 2 – P. 112-123 8. Zokirov V.Z. (2021). Chronic liver disease and covid-2019 (literature review and own data) // research journal of trauma and disability studies. // Vol.1. December-2021 – P. 1–6 9. Zokirov V.Z. (2021). Assessment of comparative analysis of the course of Non-Alcoholic Fatty Liver Disease In Middle-Aged And Elderly Patients Who Suffer Covid-19 Through Ultrasound Elastometry (Via Fibroscan). // Journal of intellectual property and human rights, // 1(6), Vol.5. December-2021 – P.18–22. 10. Zokirov V.Z. (2022). COVID 19 o’tkazgan va o’tkazmagan jigarning noalkagol yog’ xastaligi bilan og’rigan bemorlar klinikasi va labarator tahlillarining solishtirma tahlili. // Scientific Progress Markazi, // Yanvar 2022 – P. 670-675. 11. Хamrayev A.A., Yuldasheva D.H. Prevalence of non-alcoholic fatty liver disease, clinical and laboratory markers. // Central Asian Journal of Medicine // 2022 – P. 112-123. 12. ДХ Юлдашева, ЗХ Мухамедова, НС Шаджанова Patients with chronic liver disease and COVID-19 (literature review and own data). // Общество и инновации // 2021– P. 498-503. 13. AA Хамраев, Д Х Юлдашева. Клинические, лабораторные и молекулярно-генетические маркеры прогрессии неалкогольной жировой болезни печени (обзор литературы и собственные данные). // Общество и инновации // 2022 – P. 399-406.